3 Questions for Christina Davis, PharmD, Clinical Oncology Pharmacy Specialist, University of Colorado Anschutz Medical Campus, Aurora
1. How frequently do you see patients who have been on active treatment for melanoma once they complete their initial treatment phase?
For high-risk melanoma patients who have completed treatment, we usually alternate our appointments with dermatology visits. So, they will see us every six months to continue scans and education, and they will have visits with the